Sector Gamma AS Has $3.91 Million Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Sector Gamma AS cut its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 53.1% during the fourth quarter, Holdings Channel reports. The institutional investor owned 50,000 shares of the company’s stock after selling 56,700 shares during the quarter. GE HealthCare Technologies comprises 1.3% of Sector Gamma AS’s holdings, making the stock its 23rd biggest position. Sector Gamma AS’s holdings in GE HealthCare Technologies were worth $3,909,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Lee Danner & Bass Inc. acquired a new stake in GE HealthCare Technologies during the fourth quarter valued at approximately $80,000. Whittier Trust Co. of Nevada Inc. boosted its holdings in GE HealthCare Technologies by 4.4% during the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 77,355 shares of the company’s stock valued at $6,047,000 after purchasing an additional 3,240 shares in the last quarter. Whittier Trust Co. boosted its holdings in GE HealthCare Technologies by 4.4% during the fourth quarter. Whittier Trust Co. now owns 126,897 shares of the company’s stock valued at $9,921,000 after purchasing an additional 5,328 shares in the last quarter. iA Global Asset Management Inc. boosted its holdings in GE HealthCare Technologies by 38.6% during the fourth quarter. iA Global Asset Management Inc. now owns 64,538 shares of the company’s stock valued at $5,046,000 after purchasing an additional 17,987 shares in the last quarter. Finally, Teacher Retirement System of Texas boosted its holdings in GE HealthCare Technologies by 167.8% during the fourth quarter. Teacher Retirement System of Texas now owns 112,203 shares of the company’s stock valued at $8,772,000 after purchasing an additional 70,300 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

GEHC has been the topic of a number of recent research reports. Citigroup lifted their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, February 13th. Wells Fargo & Company boosted their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. Finally, Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their target price for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average target price of $98.75.

GE HealthCare Technologies Stock Performance

GEHC stock opened at $81.81 on Friday. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The company has a 50 day moving average price of $87.08 and a 200 day moving average price of $86.05. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.80. The stock has a market capitalization of $37.41 billion, a PE ratio of 18.89, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. Analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.